South Korea Dysmenorrhea Treatment Market

ID: MRFR/HC/52776-HCR
200 Pages
Rahul Gotadki
Last Updated: March 28, 2026
South Korea Dysmenorrhea Treatment Market Size, Growth Research Report By Product Type (Primary Dysmenorrhea, Secondary Dysmenorrhea), By Type of Treatment (Pain Relievers, Hormonal Therapy, Surgery), andBy End-User (Hospitals & Clinics, Research Centers)– Competitor Industry Analysis and Trends Forecast Till 2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

  1. 1 EXECUTIVE SUMMARY
    1. 1.1 Market Overview
    2. 1.2 Key Findings
    3. 1.3 Market Segmentation
    4. 1.4 Competitive Landscape
    5. 1.5 Challenges and Opportunities
    6. 1.6 Future Outlook
  2. 2 MARKET INTRODUCTION
    1. 2.1 Definition
    2. 2.2 Scope of the study
      1. 2.2.1 Research Objective
      2. 2.2.2 Assumption
      3. 2.2.3 Limitations
  3. 3 RESEARCH METHODOLOGY
    1. 3.1 Overview
    2. 3.2 Data Mining
    3. 3.3 Secondary Research
    4. 3.4 Primary Research
      1. 3.4.1 Primary Interviews and Information Gathering Process
      2. 3.4.2 Breakdown of Primary Respondents
    5. 3.5 Forecasting Model
    6. 3.6 Market Size Estimation
      1. 3.6.1 Bottom-Up Approach
      2. 3.6.2 Top-Down Approach
    7. 3.7 Data Triangulation
    8. 3.8 Validation
  4. 4 MARKET DYNAMICS
    1. 4.1 Overview
    2. 4.2 Drivers
    3. 4.3 Restraints
    4. 4.4 Opportunities
  5. 5 MARKET FACTOR ANALYSIS
    1. 5.1 Value chain Analysis
    2. 5.2 Porter's Five Forces Analysis
      1. 5.2.1 Bargaining Power of Suppliers
      2. 5.2.2 Bargaining Power of Buyers
      3. 5.2.3 Threat of New Entrants
      4. 5.2.4 Threat of Substitutes
      5. 5.2.5 Intensity of Rivalry
    3. 5.3 COVID-19 Impact Analysis
      1. 5.3.1 Market Impact Analysis
      2. 5.3.2 Regional Impact
      3. 5.3.3 Opportunity and Threat Analysis
  6. 6 South Korea Dysmenorrhea Treatment Market, BY PRODUCT TYPE (USD MILLION)
    1. 6.1 Primary Dysmenorrhea
    2. 6.2 Secondary Dysmenorrhea
  7. 7 South Korea Dysmenorrhea Treatment Market, BY TYPE OF TREATMENT (USD MILLION)
    1. 7.1 Pain Relievers
    2. 7.2 Hormonal Therapy
    3. 7.3 Surgery
  8. 8 South Korea Dysmenorrhea Treatment Market, BY END-USER (USD MILLION)
    1. 8.1 Hospitals & Clinics
    2. 8.2 Research Centers
  9. 9 COMPETITIVE LANDSCAPE
    1. 9.1 Overview
    2. 9.2 Competitive Analysis
    3. 9.3 Market share Analysis
    4. 9.4 Major Growth Strategy in the Dysmenorrhea Treatment Market
    5. 9.5 Competitive Benchmarking
    6. 9.6 Leading Players in Terms of Number of Developments in the Dysmenorrhea Treatment Market
    7. 9.7 Key developments and growth strategies
      1. 9.7.1 New Product Launch/Service Deployment
      2. 9.7.2 Merger & Acquisitions
      3. 9.7.3 Joint Ventures
    8. 9.8 Major Players Financial Matrix
      1. 9.8.1 Sales and Operating Income
      2. 9.8.2 Major Players R&D Expenditure. 2023
  10. 10 COMPANY PROFILES
    1. 10.1 Korea United Pharmaceutical
      1. 10.1.1 Financial Overview
      2. 10.1.2 Products Offered
      3. 10.1.3 Key Developments
      4. 10.1.4 SWOT Analysis
      5. 10.1.5 Key Strategies
    2. 10.2 Samyang Biopharmaceuticals
      1. 10.2.1 Financial Overview
      2. 10.2.2 Products Offered
      3. 10.2.3 Key Developments
      4. 10.2.4 SWOT Analysis
      5. 10.2.5 Key Strategies
    3. 10.3 JW Pharmaceutical
      1. 10.3.1 Financial Overview
      2. 10.3.2 Products Offered
      3. 10.3.3 Key Developments
      4. 10.3.4 SWOT Analysis
      5. 10.3.5 Key Strategies
    4. 10.4 Boryung Pharmaceutical
      1. 10.4.1 Financial Overview
      2. 10.4.2 Products Offered
      3. 10.4.3 Key Developments
      4. 10.4.4 SWOT Analysis
      5. 10.4.5 Key Strategies
    5. 10.5 Hugel
      1. 10.5.1 Financial Overview
      2. 10.5.2 Products Offered
      3. 10.5.3 Key Developments
      4. 10.5.4 SWOT Analysis
      5. 10.5.5 Key Strategies
    6. 10.6 SK Chemicals
      1. 10.6.1 Financial Overview
      2. 10.6.2 Products Offered
      3. 10.6.3 Key Developments
      4. 10.6.4 SWOT Analysis
      5. 10.6.5 Key Strategies
    7. 10.7 Medytox
      1. 10.7.1 Financial Overview
      2. 10.7.2 Products Offered
      3. 10.7.3 Key Developments
      4. 10.7.4 SWOT Analysis
      5. 10.7.5 Key Strategies
    8. 10.8 Daewoong Pharmaceutical
      1. 10.8.1 Financial Overview
      2. 10.8.2 Products Offered
      3. 10.8.3 Key Developments
      4. 10.8.4 SWOT Analysis
      5. 10.8.5 Key Strategies
    9. 10.9 LG Chem
      1. 10.9.1 Financial Overview
      2. 10.9.2 Products Offered
      3. 10.9.3 Key Developments
      4. 10.9.4 SWOT Analysis
      5. 10.9.5 Key Strategies
    10. 10.10 Hanmi Pharmaceutical
      1. 10.10.1 Financial Overview
      2. 10.10.2 Products Offered
      3. 10.10.3 Key Developments
      4. 10.10.4 SWOT Analysis
      5. 10.10.5 Key Strategies
    11. 10.11 DongA ST
      1. 10.11.1 Financial Overview
      2. 10.11.2 Products Offered
      3. 10.11.3 Key Developments
      4. 10.11.4 SWOT Analysis
      5. 10.11.5 Key Strategies
    12. 10.12 Genexine
      1. 10.12.1 Financial Overview
      2. 10.12.2 Products Offered
      3. 10.12.3 Key Developments
      4. 10.12.4 SWOT Analysis
      5. 10.12.5 Key Strategies
    13. 10.13 Chong Kun Dang Pharmaceutical
      1. 10.13.1 Financial Overview
      2. 10.13.2 Products Offered
      3. 10.13.3 Key Developments
      4. 10.13.4 SWOT Analysis
      5. 10.13.5 Key Strategies
    14. 10.14 Hana Pharma
      1. 10.14.1 Financial Overview
      2. 10.14.2 Products Offered
      3. 10.14.3 Key Developments
      4. 10.14.4 SWOT Analysis
      5. 10.14.5 Key Strategies
  11. 11 APPENDIX
    1. 11.1 References
    2. 11.2 Related Reports
  12. LIST OF TABLES
  13. TABLE 1 LIST OF ASSUMPTIONS
  14. TABLE 2 SOUTH KOREA DYSMENORRHEA TREATMENT MARKET SIZE ESTIMATES & South Korea Dysmenorrhea Treatment Market, BY PRODUCT TYPE, 2019-2035 (USD BILLIONS)
  15. TABLE 3 SOUTH KOREA DYSMENORRHEA TREATMENT MARKET SIZE ESTIMATES & South Korea Dysmenorrhea Treatment Market, BY TYPE OF TREATMENT, 2019-2035 (USD BILLIONS)
  16. TABLE 4 SOUTH KOREA DYSMENORRHEA TREATMENT MARKET SIZE ESTIMATES & South Korea Dysmenorrhea Treatment Market, BY END-USER, 2019-2035 (USD BILLIONS)
  17. TABLE 5 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  18. TABLE 6 ACQUISITION/PARTNERSHIP
  19. LIST OF FIGURES
  20. FIGURE 1 MARKET SYNOPSIS
  21. FIGURE 2 SOUTH KOREA DYSMENORRHEA TREATMENT MARKET ANALYSIS BY PRODUCT TYPE
  22. FIGURE 3 SOUTH KOREA DYSMENORRHEA TREATMENT MARKET ANALYSIS BY TYPE OF TREATMENT
  23. FIGURE 4 SOUTH KOREA DYSMENORRHEA TREATMENT MARKET ANALYSIS BY END-USER
  24. FIGURE 5 KEY BUYING CRITERIA OF DYSMENORRHEA TREATMENT MARKET
  25. FIGURE 6 RESEARCH PROCESS OF MRFR
  26. FIGURE 7 DRO ANALYSIS OF DYSMENORRHEA TREATMENT MARKET
  27. FIGURE 8 DRIVERS IMPACT ANALYSIS: DYSMENORRHEA TREATMENT MARKET
  28. FIGURE 9 RESTRAINTS IMPACT ANALYSIS: DYSMENORRHEA TREATMENT MARKET
  29. FIGURE 10 SUPPLY / VALUE CHAIN: DYSMENORRHEA TREATMENT MARKET
  30. FIGURE 11 South Korea Dysmenorrhea Treatment Market, BY PRODUCT TYPE, 2025 (% SHARE)
  31. FIGURE 12 South Korea Dysmenorrhea Treatment Market, BY PRODUCT TYPE, 2019 TO 2035 (USD Billions)
  32. FIGURE 13 South Korea Dysmenorrhea Treatment Market, BY TYPE OF TREATMENT, 2025 (% SHARE)
  33. FIGURE 14 South Korea Dysmenorrhea Treatment Market, BY TYPE OF TREATMENT, 2019 TO 2035 (USD Billions)
  34. FIGURE 15 South Korea Dysmenorrhea Treatment Market, BY END-USER, 2025 (% SHARE)
  35. FIGURE 16 South Korea Dysmenorrhea Treatment Market, BY END-USER, 2019 TO 2035 (USD Billions)
  36. FIGURE 17 BENCHMARKING OF MAJOR COMPETITORS

South Korea Dysmenorrhea Treatment Market Segmentation

  • South Korea Dysmenorrhea Treatment Market By Product Type (USD Million, 2019-2035)

    • Primary Dysmenorrhea
    • Secondary Dysmenorrhea
  • South Korea Dysmenorrhea Treatment Market By Type of Treatment (USD Million, 2019-2035)

    • Pain Relievers
    • Hormonal Therapy
    • Surgery
  • South Korea Dysmenorrhea Treatment Market By End-User (USD Million, 2019-2035)

    • Hospitals & Clinics
    • Research Centers